SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kobo Biotech informs about board meeting

11 Aug 2022 Evaluate

Kobo Biotech has informed that the Board of Directors of the company at their meeting held today on Thursday, 11th August, 2022 approved the Unaudited Financial Results of the Company for the quarter ended 30th June, 2022 along with the Limited review report of statutory auditor thereon. The company has enclosed a copy of the unaudited Financials along with Limited Review report from the Statutory Auditors. The above-referred meeting was commenced at 1.00 pm and concluded at 2:00 pm. The above is pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, for the information and record.

The above information is a part of company’s filings submitted to BSE.

Kobo Biotech Share Price

2.74 0.12 (4.58%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×